Thomas Bols serves as Senior Vice President and Managing Director for DIA Europe, Middle East, and Africa (EMEA). Thomas Bols joined DIA after a distinguished career in the biopharmaceutical industry, having held consulting and corporate international public affairs positions at Amgen, Merck KGaA, and Biogen. While working at the intersection of market access, government affairs, public affairs, health policy, corporate communications, and patient advocacy, he spearheaded initiatives that were pivotal to bringing much-needed medicines to patients.
Throughout his career, Mr. Bols has advised and represented companies and industry federations in interactions with policy makers, patient representatives, media, regulators, payers, and other national and European health policy stakeholders. He was responsible for delivering strategic objectives and tactical results that contributed to commercial success and health policy advancements at both the national and European level.
Mr. Bols held board positions at several European associations, including Europabio and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), and chaired a variety of working groups related to regulatory and access issues within the European Federation of Pharmaceutical Industries and Associations (EFPIA). He was also a member of the European Commission High Level Pharmaceutical Forum (2005-2008) and its Process on Corporate Responsibility in the Field of Pharmaceuticals (2010-2012).
Mr. Bols earned a post-graduate degree in European law from the University of Amsterdam.